Ligand Pharmaceuticals (LGND) Minority Interest (2014 - 2015)

Ligand Pharmaceuticals (LGND) posted Minority Interest of -$2.8 million for Q1 2015, down 44.14% sequentially from -$1.9 million in Q4 2014.

Ligand Pharmaceuticals (LGND) Minority Interest (2014 - 2015) Analysis & Trends

Ligand Pharmaceuticals has reported Minority Interest for 2 years, with the latest figure at -$2.8 million in Q1 2015.

Quarterly Minority Interest changed N/A year-over-year to -$2.8 million in Q1 2015, while the trailing twelve-month figure through Mar 2015 was -$2.8 million (changed N/A YoY) and the FY2014 annual result came in at -$1.9 million, changed N/A from the prior year.
Minority Interest retreated to -$2.8 million in Q1 2015 per LGND's latest filing, from -$1.9 million in the prior quarter.
Over five years, Minority Interest peaked at -$1.1 million in Q2 2014 and troughed at -$2.8 million in Q1 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Ligand Pharmaceuticals	5.87 Bn	4.51 Bn	60.48 Mn

Download Data